With Q1 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers. Over the next few years, therapeutic companies, which develop a wide variety of treatments for diseases and ...

"The Myriad' offers an institutional model that merges flexibility with community Dubai: As co-living gains momentum among Millennial and Gen Z residents, The Myriad is emerging as a standout ...

Myriad Genetics, Inc. (NASDAQ:MYGN) is making waves at the 2025 ASCO Annual Meeting, presenting seven new research studies that underscore major advances in molecular diagnostics and precision ...

As co-living continues to gain traction globally, The Myriad is setting a new benchmark in the Gulf region with a student housing model designed for a mobile, urban generation. Developed by ...

SALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share data from seven new ...

Myriad Genetics MYGN underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings ...

SYDNEY--Australian retail sales fell in April amid a myriad of factors weighing on confidence, including the approach of a federal election in early May and volatility in financial markets as ...

SYDNEY--Australian retail sales fell in April amid a myriad of factors weighing on confidence, including the approach of a federal election in early May and volatility in financial markets as ...